Bob Englert is a prominent figure in the medical device and life sciences industry, known for his experience in liquid biopsy technology development and mobile health. Having worked in senior level general management and executive positions in both large corporate and small start-up environments, Englert has expertise in marketing, R&D, engineering, quality systems, ISO/CE mark and 510k approvals, as well as interactions with a board of directors and venture capital investors. With core competencies in product development, manufacturing, quality control, commercialization, financial management, R&D, and international business, Englert has successfully launched more than thirty products, focused on laboratory and point-of-care devices for various diseases, including thyroid, metabolic, cardiovascular, and infectious diseases (HIV, hepatitis), as well as fertility, pregnancy, diabetes, and cancer diagnosis.